Opposing Views

Afinitor is First Drug Approved for Children with Rare Brain Tumor
Opposing Views
Afinitor Disperz is recommended to treat patients ages 1 year and older with tuberous sclerosis complex (TSC) who are diagnosed with SEGA that cannot be treated with surgery. Prior to approval of this new dosage form, Afinitor was recommended for use ...
FDA Approves Everolimus (Afinitor Disperz) for Rare Pediatric Brain TumorCancer Network

all 2 news articles »


More...